TY - JOUR
T1 - Cells carrying nonlymphoma-associated bcl-2/IgH rearrangements (NLABR) are phenotypically related to follicular lymphoma and can establish as long-term persisting clonal populations
AU - Ladetto, Marco
AU - Mantoan, Barbara
AU - De Marco, Federica
AU - Drandi, Daniela
AU - Aguzzi, Chiara
AU - Astolfi, Monica
AU - Vallet, Sonia
AU - Ricca, Irene
AU - Aquila, Maria Dell
AU - Pagliano, Gloria
AU - Monitillo, Luigia
AU - Pollio, Berardino
AU - Santo, Loredana
AU - Cristiano, Carmen
AU - Rocci, Alberto
AU - Francese, Roberto
AU - Bodoni, Chiara Lobetti
AU - Borchiellini, Alessandra
AU - Schinco, Piercarla
AU - Boccadoro, Mario
AU - Tarella, Corrado
N1 - Funding Information:
The study was partly supported by Compagnia di San Paolo, Turin, Italy; Regione Piemonte Torino Italy; Consiglio Nazionale delle Ricerche (CNR), Rome, Italy; and Ministero dell'Università e della Ricerca (MIUR), Rome, Italy. MDA and LM are recipients of a fellowship from Regione Piemonte Torino Italy; AR is recipient of a research fellowship from Fondazione Internazionale di Ricerca in Medicina Sperimentale (FIRMS), Torino, Italy.
PY - 2006/12
Y1 - 2006/12
N2 - Objective: Nonlymphoma-associated bcl-2/IgH rearrangements (NLABRs) are frequently amplified by PCR in blood of lymphoma-free subjects (LFS), but the temporal kinetics and phenotypic nature of NLABR-positive cells are unknown. To address these issues we prospectively monitored a panel of NLABR-positive LFS. Methods: LFS have been studied by nested PCR, real-time PCR, and DNA sequencing. Cell selection studies were also performed to define the nature of NLABR-bearing clones. Results: Of 125 donors, 16 (12.8%) were found to be bcl-2/IgH positive and were monitored at least every 6 months for a median time of 22 months (range 6-50). In half of the subjects the same NLABR detected initially was again reamplified at follow-up thrice or more. In 5, the same NLABR was constantly amplified in every follow-up sample. With a median follow-up of 22 months (range 9-50), no stable disappearance of a recurrent clone has been so far recorded. Real-time PCR indicated that persistent NLABR-positive clones are stable over time in the same subject. Cell separation studies indicate that NLABRs belong to CD19+, CD5-, CD23-, CD10+/- cells. Conclusions: Our results indicate that NLABR-positive clones are persistent populations phenotypically related to follicular lymphoma (FL). This suggests the existence of a FL-related clonal expansion of undetermined significance, which might be either a premalignant or a nonmalignant counterpart of FL.
AB - Objective: Nonlymphoma-associated bcl-2/IgH rearrangements (NLABRs) are frequently amplified by PCR in blood of lymphoma-free subjects (LFS), but the temporal kinetics and phenotypic nature of NLABR-positive cells are unknown. To address these issues we prospectively monitored a panel of NLABR-positive LFS. Methods: LFS have been studied by nested PCR, real-time PCR, and DNA sequencing. Cell selection studies were also performed to define the nature of NLABR-bearing clones. Results: Of 125 donors, 16 (12.8%) were found to be bcl-2/IgH positive and were monitored at least every 6 months for a median time of 22 months (range 6-50). In half of the subjects the same NLABR detected initially was again reamplified at follow-up thrice or more. In 5, the same NLABR was constantly amplified in every follow-up sample. With a median follow-up of 22 months (range 9-50), no stable disappearance of a recurrent clone has been so far recorded. Real-time PCR indicated that persistent NLABR-positive clones are stable over time in the same subject. Cell separation studies indicate that NLABRs belong to CD19+, CD5-, CD23-, CD10+/- cells. Conclusions: Our results indicate that NLABR-positive clones are persistent populations phenotypically related to follicular lymphoma (FL). This suggests the existence of a FL-related clonal expansion of undetermined significance, which might be either a premalignant or a nonmalignant counterpart of FL.
UR - http://www.scopus.com/inward/record.url?scp=33751529671&partnerID=8YFLogxK
U2 - 10.1016/j.exphem.2006.08.008
DO - 10.1016/j.exphem.2006.08.008
M3 - Journal article
C2 - 17157165
AN - SCOPUS:33751529671
SN - 0301-472X
VL - 34
SP - 1680
EP - 1686
JO - Experimental Hematology
JF - Experimental Hematology
IS - 12
ER -